## **Core Concept**
Type-I hyperlipoproteinemia, also known as hyperchylomicronemia, is a rare genetic disorder characterized by the elevated levels of chylomicrons in the blood. This condition results from a deficiency in lipoprotein lipase (LPL) or altered apolipoprotein C-II (apoC-II), which are crucial for the breakdown of triglycerides within chylomicrons.

## **Why the Correct Answer is Right**
The correct answer, , is right because Type-I hyperlipoproteinemia is indeed characterized by elevated levels of chylomicrons, which are lipoproteins that transport dietary lipids from the intestines to other locations in the body. The elevated chylomicron levels lead to high levels of triglycerides in the blood, causing hypertriglyceridemia. This condition is associated with lipoprotein lipase deficiency or dysfunction, which impairs the hydrolysis of triglycerides within chylomicrons.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because Type-I hyperlipoproteinemia is specifically associated with elevated chylomicrons, not with isolated increases in LDL (low-density lipoproteins).
- **Option B:** This option is incorrect as it suggests an increase in VLDL (very-low-density lipoproteins) without mentioning chylomicrons, which are the hallmark of Type-I hyperlipoproteinemia.
- **Option D:** This option is incorrect because it mentions HDL (high-density lipoproteins) and LDL, which are not directly related to the primary defect seen in Type-I hyperlipoproteinemia.

## **Clinical Pearl / High-Yield Fact**
A key clinical feature of Type-I hyperlipoproteinemia is the presence of eruptive xanthomas (small, yellowish skin eruptions) and hepatosplenomegaly due to the accumulation of lipids. A critical laboratory finding is the "cream" layer of chylomicrons on top of a refrigerated blood sample. This condition requires dietary management to reduce triglyceride intake.

## **Correct Answer:** .